International AIDS Vaccine Initiative

International AIDS Vaccine Initiative

International AIDS Vaccine Initiative

Overview
Date Founded

1996

Headquarters

125 BROAD STREET NO 9TH FL, NEW YORK, NY, 10004

Charitable Causes

Philanthropy, Voluntarism, and Grantmaking Foundations
International Development & Relief
AIDS

Employees (Worldwide)

172

Industries

Pharmaceuticals
Medical Support Services

Company Description

International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.

Contact Data
Trying to get in touch with decision makers at International AIDS Vaccine Initiative? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founding Member

President, Chief Executive Officer & Director

Vice President Human Resources, Assistant Secretary

Executive Director, Viral Vaccines

Chief Financial Officer

Senior Vice President, Secretary & General Counsel

Chief Medical Officer

Partner

Head, Prospect Research & Development Operations

Senior Director, Medical Affairs

Board of Directors

Professor of Clinical Medicine, Department of Medicine at UCSF School of Medicine

President, Chief Executive Officer & Director at International AIDS Vaccine Initiative

Managing Director, Office of the U.N. Special Envoy for Malaria at United Nations

Former President & Chief Executive Officer at Pathfinder International

Member, Scientific Advisory Committee at Bill & Melinda Gates Foundation

Chief of Staff at The Global Fund to Fight AIDS, Tuberculosis & Malaria

President, Global Vaccine Business Unit at Takeda Pharmaceutical Co., Ltd.

Consultant at Spencer Stuart, Inc.

President & Director at Sanofi Pasteur VaxDesign Corp.

Director at Aeras Global TB Vaccine Foundation

Paths to International AIDS Vaccine Initiative
Potential Connections via
Relationship Science
You
International AIDS Vaccine Initiative
Recent Transactions
Details Hidden

International AIDS Vaccine Initiative purchases Aeras Global TB Vaccine Foundation

Advisors & Consultants
Consultant

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Legal Advisor

Duane Morris LLP provides legal services in the areas of intellectual property, telecommunications, information technologies, energy, water resources, endangered species and international dispute. The firm's clients include the automotive, construction, energy and insurance industries. The company was founded in 1904 and is headquartered in Philadelphia, PA.

Legal Advisor

Stradley Ronon Stevens & Young LLP provides legal services. Its clients include banks, health care providers, Internet companies, lenders & borrowers, manufacturing companies, emerging & start-up companies, brokers & dealers, and technical companies. The company was founded in 1926 and is headquartered in Philadelphia, PA.

Legal Advisor

Partner at White & Case LLP

Consultant

Senior Vice President, Strategic Partnerships at The Energy Foundation

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$88.5M
Non-Profit Donations & Grants Received
$1,000
12/31/2016
Suppliers
Celldex Therapeutics Inc. Pension Funds & Sovereign Wealth | Hampton, NJ

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Valneva SE Hospitals & Patient Services | Saint-herblain, France

Valneva SE is a biotech company. The firm engages in the development, production and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. The Technologies and Services segment regroups services and inventions in commercialization stage. The Vaccine Candidates segment consists of proprietary research and development programs aiming to generate new approvable products. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

Kemper Cost Management, Inc. Other Insurance Services | Oklahoma City, OK

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by International AIDS Vaccine Initiative. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of International AIDS Vaccine Initiative's profile does not indicate a business or promotional relationship of any kind between RelSci and International AIDS Vaccine Initiative.